News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
5 years in, RECOVER continues to advance its patient-centered mission
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.
News Release
150 Results
150 Results
NIH-funded study finds cases of ME/CFS increase following COVID-19
Results from a recent RECOVER study suggest that adults who have COVID-19 may be more likely to develop a related condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
News Release
NIH hosts January 10 webinar to discuss RECOVER-TLC’s progress
NIH leaders will provide updates and answer questions about RECOVER’s latest efforts to identify safe and effective treatments for Long COVID.
Announcement
R3 Seminar Recap: Persistent SARS-CoV-2 antigens and correlation with Long COVID symptoms: Findings from a multi-cohort study
During the December 10th RECOVER Research Review (R3) Seminar, researchers described a recent pathobiology study investigating viral persistence, or when SARS-CoV-2 remains in a person’s body and continues to cause changes even after they recover from their initial sickness. The study’s findings suggest that viral persistence could be one reason why some people experience certain symptoms of Long COVID.
R3 Seminar Recap
New insights on Long COVID symptoms in adults highlight update to RECOVER study findings
Data provided by more than 3,800 new study participants reinforce how the long-term effects of COVID-19 can be different for everyone.
Announcement
Reviewing RECOVER’s impact in 2024
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
Feature
RECOVER’s tissue pathology (autopsy) study makes unique contributions to Long COVID research
Using a large and diverse collection of tissue samples, experts in how diseases affect different parts of the body will explore the underlying causes of Long COVID.
Feature
NIH directors highlight RECOVER’s progress and impact
Editorial by NIH leaders shares how RECOVER has worked and will continue working to ease the suffering of those living with Long COVID.
Announcement
NIH adds funds to Long COVID research, advances work on new clinical trials
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
News Release